Tocqueville Asset Management L.P. Regenxbio Inc. Transaction History

Tocqueville Asset Management L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 14, 2020	SELL	$34.54 - $44.87 $433,304 - $562,894	-12,545 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$31.84 - $50.88 $796 - $1,272	25 Added 0.2%	12,545 $447,000
Q1 2019 Apr 30, 2019	BUY	$40.82 - $62.45 $256,145 - $391,873	6,275 Added 100.48%	12,520 $718,000
Q4 2018 Feb 08, 2019	SELL	$39.11 - $75.15 $234,660 - $450,900	-6,000 Reduced 49.0%	6,245 $262,000
Q3 2018 Nov 13, 2018	BUY	$65.0 - $82.15 $102,050 - $128,975	1,570 Added 14.71%	12,245 $924,000
Q2 2018 Aug 13, 2018	BUY	$27.2 - $74.35 $290,360 - $793,686	10,675 New	10,675 $766,000

188

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $364M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.